Amador Bioscience Welcomes Dr. Lorin Roskos as Chief Scientific Officer and President of Quantitative Clinical Pharmacology

PLEASANTON, Calif., May 5, 2023 /PRNewswire/ -- Amador Bioscience, a full-service CRO with global expertise in translational research and clinical development, has announced the appointment of Dr. Lorin Roskos as Chief Scientific Officer (CSO) and President of Quantitative Clinical...

Click to view original post